Showing 158 news articles about TB treatment

Filters Content type: Editors' picks Topic: TB treatment

Active tuberculosis (TB) disease is treated with a combination of antibiotics. Successful treatment usually requires at least six months of therapy, without missing doses. People living with HIV also need to take HIV treatment, but it may be started a few weeks after TB treatment. Care is needed when taking TB and HIV treatment at the same time.

Access to healthcare

High price excludes patients from better treatment for drug-resistant TB

Editor's pick
Devex
29 June 2020
TB treatment

Systematic, test-guided TB treatment result in similar outcomes

Editor's pick
Healio
18 June 2020
Drug interactions & pharmacokinetics

Darunavir/Ritonavir With Rifampicin May Be Hepatotoxic

Editor's pick
Infectious Disease Advisor
17 April 2020
TB treatment

New Consortium Aims To Develop “Pan-TB” Treament Regimen

Editor's pick
Health Policy Watch
2 March 2020
Tuberculosis & HIV

Six highlights from a week of important TB developments

Editor's pick
Spotlight
7 November 2019
Access to healthcare

TB Survivors Disrupt Global Conference, Demand That Drugs Be Made Cheaper

Editor's pick
The Wire
4 November 2019
Clinical trials

Opinion: Approval of new TB drug lays bare crisis in TB research

Editor's pick
Spotlight
20 August 2019
Drug-resistant TB

Promising new tuberculosis drug approved, but will it be affordable?

Editor's pick
Médecins Sans Frontières (MSF)
16 August 2019
TB treatment

Statement from Treatment Action Group on U.S. FDA Approval of Pretomanid

Editor's pick
Treatment Action Group
15 August 2019
Drug-resistant TB

FDA approves tuberculosis drug that works on hard-to-treat cases

Editor's pick
Los Angeles Times
15 August 2019
TB treatment

Will a new TB treatment be available soon?

Editor's pick
Devex
8 July 2019
Pharmaceutical industry

Will new TB treatments reach those who need them most?

Editor's pick
Devex
15 April 2019
Drug interactions & pharmacokinetics

Double doses of darunavir given with rifampicin lead to high rates of hepatoxicity

Editor's pick
HIV i-Base
12 March 2019
TB treatment

Pulmonary TB can be cured with shorter treatment, study finds

Editor's pick
Eurekalert Inf Dis
6 November 2018
TB treatment

Ending tuberculosis will take lower drug prices and a new, improved innovation ecosystem

Editor's pick
STAT
13 September 2018
TB treatment

SimpliciTB Clinical Trial Launched with First Patients in Tbilisi, Georgia

Editor's pick
TB Alliance
28 August 2018
TB treatment

How smartphones are becoming a weapon in the global fight against tuberculosis

Editor's pick
STAT
21 August 2018
TB treatment

South Africa strikes deal on new TB drug as WHO revisits guidance

Editor's pick
Devex
13 August 2018
TB treatment

AIDS 2018: Price of bedaquiline drops in South Africa, will replace injectable TB drugs, Minister of Health announces

Editor's pick
Science Speaks
23 July 2018
TB treatment

Higher doses of rifampin appear more effective in fighting TB without increasing risk of adverse events

Editor's pick
Eurekalert Inf Dis
29 June 2018
TB treatment

Could a New Universal Tuberculosis Regimen Help End the TB Pandemic?

Editor's pick
Infectious Disease Advisor
29 May 2018
TB treatment

Smartphone app keeps an 'eye' on daily tuberculosis therapy

Editor's pick
Eurekalert Inf Dis
27 April 2018
TB treatment

TB Treatment May Leave Some Patients Contagious

Editor's pick
New York Times
9 April 2018
TB treatment

Higher rifampin doses safe for patients with pulmonary TB

Editor's pick
Healio
7 March 2018